| Opening Keynote Session: International Collaboration for Better Healthcare
|
Fostering Collaboration to Accelerate Better Patient Outcomes
- John Wubbe, Secretary General & CEO, EPOSSI
- Marshall Summar, Chair, NORD Scientific and Medical Advisory Committee and Board Member
- Pat Furlong, Founding President & CEO, Parent Project Muscular Dystrophy
- Anders Olauson, President, European Patients’ Forum
|
New Data Models: Managing Uncertainty and Leveraging New Sources of Evidence
- Sabine Atzor, Director Regulatory Affairs, part time seconded from F.Hoffmann-La Roche to EFPIA
- Kenneth Oye, Associate Professor of Political Science and Engineering Systems, MIT
- Bettina Ryll, Founder, Melanoma Patient Network
- Arti K. Rai, Elvin R. Latty Professor of Law, Duke Law Center for Innovation Policy
|
Implementing Personalized Medicine, Determining Economic Value
- Laura Esserman, Professor of Surgery and Radiology, Director UCSF Carol Franc Buck Breast Care Center
- Mark Trusheim, Executive-in-Residence, MIT
|
Next Generation Innovations in Regulatory Science
- Gigi Hirsch, Executive Director, MIT Center for Biomedical Innovation; Program Director, NEWDIGS
- Carol Linden, Director Office of Regulatory Science and Innovation, FDA
- Sandra Milligan, Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety, Merck
Combined slide deck.
|
Real World Evidence: Moving Beyond the Hype
- Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE)
- Jeff Brown, Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
|
| New Models for Patient Engagement: Improving Research Participation
|
